Using a Filtration Technique to Isolate Platelet Free Plasma for Assaying Pyrophosphate

• Type of Material: Article
• Authors: Ramin Tolouian, Texas Tech University; Sean M. Connery, Texas Tech University; William O'Neill, Emory University; Ajay Gupta, UCLA
• Language: English
• Date: 2012-01-01
• Publisher: Clinical Laboratory Publications
• Publication Version: Author Accepted Manuscript (After Peer Review)
• Copyright Statement: © 2012 Clinical Laboratory Publications
• Final Published Version (URL): http://dx.doi.org/10.7754/Clin.Lab.2012.111101
• Title of Journal or Parent Work: Clinical Laboratory
• ISSN: 1433-6510
• Volume: 58
• Issue: 11-12
• Start Page: 1129
• End Page: 1134
• Grant/Funding Information: NIH Grant DK069681 to W.C.O.; NIH/NIDDK 5-R01-DK066361-01 to AG.; Paul L. Foster School of Medicine Seed Grant and Lizanell & Colbert Coldwell Foundation Grant to R.T.
• Keywords: vascular calcification; VASCULAR CALCIFICATION; Life Sciences & Biomedicine; Medical Laboratory Technology; filtration method; Pyrophosphate; CHRONIC KIDNEY-DISEASE; CALCIUM HOMEOSTASIS; platelet free plasma; hemodialysis; INORGANIC PYROPHOSPHATE; PHOSPHATE; MEDICAL LABORATORY TECHNOLOGY; Science & Technology; UREMIA; OSTEOPONTIN

Abstract

Background: Vascular calcification (VC) is a strong prognostic marker of mortality from cardiovascular disease. Extracellular inorganic pyrophosphate (PPi) is a critical inhibitor of vascular calcification and it has been reported that hemodialysis patients have reduced plasma PPi levels, suggesting that altered PPi metabolism could contribute to VC in hemodialysis patients. Platelets are rich in PPi and release of PPi from platelets during storage or processing of plasma can lead to falsely elevated plasma PPi levels. To prepare plasma samples that are suitable for measuring PPi levels, ultracentrifugation has been used to remove platelets. Consequently, plasma PPi measurements have been limited to research laboratories since the majority of clinical laboratories do not have access to an ultracentrifuge. The purpose of the present study was to test the validity of an improved method of preparing platelet free plasma that uses filtration with a 300,000 Dalton molecular weight cut-off filter to exclude platelets, while minimizing their release of PPi. Methods: In 20 maintenance hemodialysis patients, PPi levels were measured in plasma samples prepared by the conventional technique of low-speed centrifugation to remove red and white blood cells versus a novel filtration technique. Results: Plasma prepared by filtration had significantly lower platelet counts (0 vs. 3-7 103/μL) and PPi levels (1.39 ± 0.30 μM vs. 2.74 ± 1.19 μM; mean ± SD, p < 0.01). Conclusions: The filtration method appears effective in excluding platelets without causing trauma to platelets and can be used by clinical laboratories to prepare platelet-depleted plasma for PPi measurement.